Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Atacand and associated names

Product name: Atacand and associated names
Also marketed in the EU under the name(s): Amias, Blopress, Kenzen, Parapres, Racanda, Ratacand
Active substance: candesartan cilexetil
Indication: - Treatment of essential hypertension in adults.
- Treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction = 40%) as add-on therapy to Angiotensin Converting Enzyme (ACE) inhibitors or when ACE inhibitors are not tolerated
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/07/2010 Referral EMEA/H/A-30/1150 (2010)4993 of 13/07/2010
26/09/2011 Corrigendum (2011)6930 of 22/09/2011